NCT06455293: Psilocybin Therapy for Depression in Parkinson's Disease
- State
- Under way
- Phase
- Phase 2
- People
- 60 planned
- Started
- 19 Aug 2024
- Primary completion
- Jun 2027
- Arms
- Psilocybin Administration Session 1, Psilocybin Administration Session 2
- Results
- None posted
- 12 Jun 2024: Trial registered
- 19 Aug 2024: Trial started